A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations.
about
Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial.Patient-Reported Outcomes From a Two-Year Head-to-Head Comparison of Subcutaneous Abatacept and Adalimumab for Rheumatoid Arthritis.Unintended Immunological Consequences of Biologic Therapy.
P2860
A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A critical evaluation of the r ...... ritis: patient considerations.
@en
A critical evaluation of the r ...... ritis: patient considerations.
@nl
type
label
A critical evaluation of the r ...... ritis: patient considerations.
@en
A critical evaluation of the r ...... ritis: patient considerations.
@nl
prefLabel
A critical evaluation of the r ...... ritis: patient considerations.
@en
A critical evaluation of the r ...... ritis: patient considerations.
@nl
P2093
P2860
P356
P1476
A critical evaluation of the r ...... ritis: patient considerations.
@en
P2093
Alvin F Wells
Michael Schiff
Nicole Jodat
P2860
P356
10.2147/BTT.S55783
P577
2014-02-17T00:00:00Z